Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Alerts, recalls and safety information: medicines and medical devices
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Marketing authorisations and licensing guidance
- Product information about medicines
- Medical devices regulation and safety
- Latest information for patients
- MHRA guidance on coronavirus (COVID-19)
- About MHRA
- All MHRA services and information
Featured
The vaccine was approved after it was found to meet the MHRA’s standards of safety, quality and effectiveness.
A new regional centre to promote Yellow Card reporting has been launched in Belfast today.
Berkshire couple receive prison sentence for illegal possession and supply of £1.6m of unlicensed medicines
Press release
Karina Filimonova and Andrejs Stolarovs were each sentenced at Southwark Crown Court to eight months in prison for the illegal possession and intent to supply unlicensed medicines, including prescription only medicines, valued at £1.6m following investigations by the Medicines and Healthcare products Regulatory Agency (MHRA).
MHRA Corporate Plan: 2023 to 2026 and Business Plan: 2023 to 2024
Corporate report
These reports outline the MHRA’s Corporate and Business Plans, detailing the agency’s strategic direction over the next three years.
MHRA approves Pfizer/BioNTech’s adapted COVID-19 vaccine (Comirnaty) that targets Omicron XBB.1.5
News story
The vaccine was approved after it was found to meet the UK regulator’s standards of safety, quality and effectiveness
Guidance published on the new international regulatory recognition routes for medicines approvals
News story
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued detailed guidance on the new International Recognition Procedure (IRP) for medicines manufacturers, including how to apply for a medicine licence.
Latest from the Medicines and Healthcare products Regulatory Agency
What we do
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Transparency and freedom of information releases
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhragovuk.
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
10 South Colonnade
London
E14 4PU
United Kingdom